A cost comparison of alternative regimens for treatment-refractory partial seizure disorder: An econometric analysis

Clinical Therapeutics

Volumn 27, Issue 10, 2005, Pages 1629-1638

  Lee, Won Chan ^a   Hoffmann, Marc S ^a   Arcona, Steve ^b   D'Souza, Joseph ^b   Wang, Qin ^a   Pashos, Chris L ^a  

^a ABT ASSOCIATES   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Costs; Managed care; Partial seizure disorder; Refractory

Indexed keywords

ANTICONVULSIVE AGENT; OXCARBAZEPINE;

ADULT; AGE DISTRIBUTION; ANAMNESIS; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA BASE; DEMOGRAPHY; ECONOMIC ASPECT; EMERGENCY WARD; FEMALE; GEOGRAPHY; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HEALTH VISITOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIVARIATE ANALYSIS; PHARMACY; RANK SUM TEST; RISK ASSESSMENT; SEIZURE; SEX DIFFERENCE; STATISTICAL ANALYSIS;

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; COSTS AND COST ANALYSIS; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FEMALE; HEALTH EXPENDITURES; HUMANS; LINEAR MODELS; MALE; MANAGED CARE PROGRAMS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 28444440886     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2005.10.020     Document Type: Article

References (15)

1. So E.L. Classifications and epidemiologic considerations of epileptic seizures and epilepsy Neuroimaging Clin N Am 5 1995 513 526
2. Begley C.E., Famulari M., and Annegers J.F. The cost of epilepsy in the United States: An estimate from populationbased clinical and survey data Epilepsia 41 2000 342 351
3. Hauser W.A. Recent developments in the epidemiology of epilepsy Acta Neurol Scand Suppl 162 1995 17 21
4. Murray M.I., Halpern M.T., and Leppik I.E. Cost of refractory epilepsy in adults in the USA Epilepsy Res 23 1996 139 148
5. Begley C.E., Annegers J.F., and Lairson D.R. Cost of epilepsy in the United States: A model based on incidence and prognosis Epilepsia 35 1994 1230 1243
6. Greene W.H. Econometric Analysis 5th ed. 2003 Prentice-Hall Upper Saddle River, NJ
7. Begley C.E., Lairson D.R., Reynolds T.F., and Coan S. Early treatment cost in epilepsy and how it varies with seizure type and frequency Epilepsy Res 47 2001 205 215
8. Ben-Menachem E., Hellstrom K., and Verstappen D. Analysis of direct hospital costs before and 18 months after treatment with vagus nerve stimulation therapy in 43 patients Neurology 59 Suppl 4 2002 S44 S47
9. Demographics and cost of epilepsy. Based on a presentation by John F. Annegers, PhD. Am J Manag Care 4 Suppl 9 1998 S453 S462
10. Griffiths R.I., Schrammel P.N., and Morris G.L. Payer costs of patients diagnosed with epilepsy Epilepsia 40 1999 351 358
11. Frost F.J., Hurley J.S., and Petersen H.V. A comparison of two methods for estimating the health care costs of epilepsy Epilepsia 41 2000 1020 1026
12. Platt M., and Sperling M.R. A comparison of surgical and medical costs for refractory epilepsy Epilepsia 43 Suppl 4 2002 25 31
13. Halpern M., Rentz A., and Murray M. Cost of illness of epilepsy in the US: Comparison of patient-based and populationbased estimates Neuroepidemiology 19 2000 87 99
14. Begley C.E., and Beghi E. The economic cost of epilepsy: A review of the literature Epilepsia 43 Suppl 4 2002 3 9
15. Begley C.E., Beghi E., and Beran R.G. ILAE Commission on the Burden of Epilepsy, Submission on the Economic Burden of Epilepsy: Final report 1998-2001 Epilepsia 43 2002 668 673